Cargando…
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
Alzheimer disease (AD) is an increasingly common neurodegenerative disease, especially in countries with aging populations. Its diagnosis is complex and is usually carried out in advanced stages of the disease. In addition, lipids and oxidative stress have been related to AD since the earliest stage...
Autores principales: | Peña-Bautista, Carmen, Álvarez-Sánchez, Lourdes, Ferrer, Inés, López-Nogueroles, Marina, Cañada-Martínez, Antonio José, Oger, Camille, Galano, Jean-Marie, Durand, Thierry, Baquero, Miguel, Cháfer-Pericás, Consuelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300760/ https://www.ncbi.nlm.nih.gov/pubmed/34209667 http://dx.doi.org/10.3390/antiox10071043 |
Ejemplares similares
-
New screening approach for Alzheimer’s disease risk assessment from urine lipid peroxidation compounds
por: Peña-Bautista, Carmen, et al.
Publicado: (2019) -
Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2020) -
Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
por: Ferré-González, Laura, et al.
Publicado: (2022) -
Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
por: Peña-Bautista, Carmen, et al.
Publicado: (2021) -
Oxidative Damage of DNA as Early Marker of Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2019)